Cullinan Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CEONadim Ahmed
CEONadim Ahmed
Employees111
Employees111
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2016
Founded2016
Employees111
Employees111
CGEM Key Statistics
Market cap449.69M
Market cap449.69M
Price-Earnings ratio-2.47
Price-Earnings ratio-2.47
Dividend yield—
Dividend yield—
Average volume449.82K
Average volume449.82K
High today$7.97
High today$7.97
Low today$7.26
Low today$7.26
Open price$7.50
Open price$7.50
Volume359.42K
Volume359.42K
52 Week high$21.01
52 Week high$21.01
52 Week low$6.85
52 Week low$6.85
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CGEM. This list is generated using Robinhood data, and it’s not a recommendation.